Rochester, NY 9/3/2009 10:14:55 PM
AVII AVI Biopharma, Inc., Late morning update trade at 1.74
Biopharma, Inc.
StockEinstein.com offers free trading alerts on stocks about to run. To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.
Last Trade: 1.74
Trade Time: 10:42am ET
Change: Down 0.04 (2.25%)
Prev Close: 1.78
Open: 1.88
Day's Range: 1.72 - 1.88
52wk Range: 0.45 - 2.73
Volume: 1,669,135
Avg Vol (3m): 2,880,670
Market Cap: 149.16M
About Biopharma, Inc.
AVI BioPharma, Inc. (AVI) is a biopharmaceutical company specializing in the discovery and development of ribonucleic acid (RNA)-based drugs targeting a range of diseases. The Company has developed and optimized derivatives of its antisense chemistry (phosphorodiamidate morpholino oligomers (PMOs)) that can be designed to target disease mechanisms through mechanisms of action. The applications of AVI’s RNA technology platform include genetic diseases (Duchenne muscular dystrophy (DMD)), infectious diseases (Ebola and Marburg viruses), cardiovascular disease (restenosis) and other early discovery targets. Several of its antiviral programs, including Ebola, Marburg, Junin and Dengue, have been or are funded by the United States government, and other governmental and non-governmental funding. On March 20, 2008, the Company acquired Ercole Biotechnology, Inc. (Ercole).
About StockEinstein
StockEinstein.com uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll down this page or visit our site to join our free newsletter and begin receiving daily stock alerts.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
